Open access
Sep 2026
FXYD5 promotes the growth of glioblastoma by targeting the PI3K/AKT/ACSL4 signaling axis
Glioblastoma (GBM) is the most malignant primary brain tumor, with limited therapeutic options. Dysregulation of FXYD5 has been reported in multiple malignancies, suggesting FXYD5 as a potential target for precision medicine. In the present study, FXYD5 expression and prognostic significance were analyzed using biologi...
Bang-Rong Wang, Yong Qin, Hang Cheng et al.
· Oncology Report · 0 citations